Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 09, 2025 17:30 ET | Source: The Rosen Law Firm PA

SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Soleno...
October 09, 2025 12:35 ET | Source: Bragar Eagel & Squire

SOLENO (SLNO) REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Soleno Therapeutics, Inc. and Encourages Investors to Contact the Firm

Scorpion Capital alleged Soleno’s sole product, Vykat XR, was overpriced and unsafe for children, causing shares to drop 7.4% to $71.63 on August 15, 2025.
October 06, 2025 19:44 ET | Source: The Rosen Law Firm PA

SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Soleno...
September 26, 2025 16:46 ET | Source: The Rosen Law Firm PA

SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Soleno...
September 25, 2025 17:10 ET | Source: Bragar Eagel & Squire

SOLENO INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the Firm

Scorpion Capital report alleged Soleno’s Vykat XR was overpriced, unsafe for kids; shares fell $5.73, or 7.4%, closing at $71.63 on Aug 15, 2025.
September 23, 2025 23:22 ET | Source: The Rosen Law Firm PA

SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Soleno...
September 18, 2025 17:40 ET | Source: Bragar Eagel & Squire

SOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating Soleno Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the Firm

Scorpion Capital alleged Soleno’s sole product Vykat XR is overpriced and unsafe for kids. Shares dropped 7.4%, closing at $71.63 on Aug. 15, 2025.
September 13, 2025 15:15 ET | Source: The Rosen Law Firm PA

SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Sept. 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Soleno...
September 11, 2025 17:06 ET | Source: Bragar Eagel & Squire

SOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating Soleno Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the Firm

On Aug. 15, 2025, Scorpion Capital alleged Soleno’s Vykat XR was overpriced and unsafe for kids; Soleno stock fell 7.41% that day.
September 08, 2025 17:07 ET | Source: Bragar Eagel & Squire

SOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating Soleno Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the Firm

On Aug 15, 2025, a Scorpion report called Soleno’s drug overpriced and unsafe; shares fell 7.4% to $71.63.